1Diekstein K,Cohen-Solal A,Filippatos G. ESC committee for practice guidelines (CPG).ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008:the task force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology.Developed in collaboration with the Heart Failure Association of the ESC (HFA)and endorsed by the European Society of Intensive Care Medicine (E[J].European Journal of Heart Failure,2008.933-989.
2Schaufelberger M,Swedberg K,Koster M. Decreasing one-year mortality and hospitalization rates for heart failure in sweden:data from the swedish hospital diacharge registry 1988 to 2000[J].European Heart Journal,2004.300-307.doi:10.1016/j.ehj.2003.12.012.
3Levy D,Kenchaiah S,Lardon MG. Long-term trends in the incidence of and survival with heart failure[J].New England Journal of Medicine,2002.1397-1402.
4Felker GM,Allen LA,Pocock SJ. CHARM Investigators.Red cell distribution width as a novel prognostic marker in heart failure:dats from the CHARM program and the duke databank[J].Journal of the American College of Cardiology,2007.40-47.
5Pecini R,Mφller DV,Torp-Pedersen C. Heart failure etology impacts survival of patients with heart failure[J].lnt J Cardio1,2010.
6Banno S,Ito Y,Tanaka C. Quantification of red blood cell fragmentation by the automated hematology analyzer XE-2100 in patients with living donor liver transplantation[J].Clin Lab Haemato1,2005.292-296.
7Lippi G,Targher G,Montagnana M. Relationship between red blood cell distribution width and kidney function tests in a large cohort of unseleeted outpatients[J].Scand J Clin Lab Invvest,2008.745-748.
8Cakal B,Akoz AG,Ustundag Y. Red cell distribution width for assessment of activity of inflammatory bowel disease[J].Digestive Diseases and Sciences,2009.842-847.
9Forhecz Z,Gombos T,Borgulya G. Red cell distribution width in heart failure:prediction of clinical events and relationship with markeers of ineffective erythropoiesis,inflammation,renal function,and nutritional state[J].American Heart Journal,2009.659-o66.
10Qipshidze N,Tyagi N,Sen U. Folic acid mitigated cardiac dysfunction by normalizing the levels of tissue inhibitor of metalloproteinase and homocysteine-metaboilzing enzymes postmyocardial infarction in mice[J].American Journal of Physiology-Heart and Circulatory Physiology,2010.1484-1493.
